about
Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.The next generation of positron emission tomography radiopharmaceuticals in oncology.Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.Imaging tumor burden in the brain with 89Zr-transferrinClinical PET-MR Imaging in Breast Cancer and Lung CancerPercutaneous Embolization of a Pulmonary Vein Pseudoaneurysm Secondary to Vascular Erosion of a Metastatic MassAssociation between changes in suspicious prostate lesions on serial MRI examinations and follow-up biopsy resultsCancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents
P50
Q34762185-00421892-F1A6-4C0A-9F6C-F4EE6D046ADAQ35525690-FC985AAA-A4C2-45F2-B03D-1A3F666D55EEQ35956405-3D74CB7E-BF6D-4B6F-BBDB-91D8DA3E5805Q37106244-9C60F38A-E5B9-4870-866A-CC8DF1BBBAC3Q38945974-E02CB39C-E8E5-4F9F-888F-B0E4B953E7D0Q59783552-080BACC3-4602-406A-9A59-D2F09D2E8DE8Q86133046-84EEE67F-0CA5-4411-8C49-4FF72E3F8E0FQ91409422-6A682348-EF0E-4140-BD6A-0B882C0896C9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Samuel L Rice
@ast
Samuel L Rice
@en
Samuel L Rice
@es
Samuel L Rice
@nl
type
label
Samuel L Rice
@ast
Samuel L Rice
@en
Samuel L Rice
@es
Samuel L Rice
@nl
prefLabel
Samuel L Rice
@ast
Samuel L Rice
@en
Samuel L Rice
@es
Samuel L Rice
@nl
P106
P1153
51764202600
P21
P31
P496
0000-0002-0158-8921